Author: OurCrowd

[Scopio in PR Newswire] Scopio Labs awarded FDA clearance for high throughput hematology digital cell morphology platform, replacing microscopes with digitization 

TEL AVIV, Israel, June 9, 2022 /PRNewswire/ — Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, announced today that its ground-breaking X100HT device with Peripheral Blood Smear (PBS) Application has received U.S. FDA 510(k) clearance. Coupling high throughput capabilities with the highest resolution for hematological analysis, the X100HT caters to major medical facilities and labs across the world. Read...

Read More

[PlaySight in GlobeNewsWire] IMG Academy Expands Partnership with PlaySight, Bringing Connected Camera Sports Technology Platform to Tennis Facilities

BALTIMORE, June 09, 2022 (GLOBE NEWSWIRE) — Connexa Sports Technologies Inc. (OTCQB: CNXA) (www.connexasports.com) is pleased to announce that its wholly owned subsidiary, PlaySight Interactive (www.playsight.com) is expanding its partnership with the world-renowned IMG Academy. PlaySight first partnered with IMG Academy back in 2020 through its baseball program, who rely on PlaySight’s pioneering sports technology platform for live streaming, remote scouting, and recruiting, as well as player performance and film breakdowns. With the expansion to tennis, PlaySight is bringing its tech to IMG Tennis and all 55 of its courts at the Bradenton, Florida campus. Read more...

Read More